India emerges as world-class cost-effective healthcare destination, global pharma leader: Jitin Prasada

The Minister urged the industry to focus on innovation, quality and work with the world market.

Written By :  Ruchika Sharma
Published On 2024-08-29 07:30 GMT   |   Update On 2024-08-29 07:31 GMT
Advertisement

New Delhi: Union Minister of State for Commerce & Industry Shri Jitin Prasada said that India has emerged as a world-class cost-effective healthcare destination and global pharma leader. The Minister stated this while inaugurating the three day International Exhibition For Pharma And Healthcare Exhibition (IPHEX 2024) organised by Pharma Export Promotion Council of India (CAPEXIL) and Ministry of Commerce and Industry at Greater Noida, Uttar Pradesh. He urged the Indian Pharmaceutical industry to work towards becoming the healthcare custodian of the world.

Advertisement

He urged the pharma industry to increase exports and seize emerging opportunities for growth. Shri Prasada said that India is already recognized as the 'pharmacy of the world'. It's extremely important that we focus not only on our strengths in the generic sector, but also ensure our backward and forward linkages, the Minister added. He further noted that its important that we try product development and break new grounds.

Read also: Exemed Pharmaceutical Gets CDSCO Panel Nod To Manufacture, Market Empagliflozin plus Sitagliptin FDC

The Minister urged the industry to focus on innovation, quality and work with the world market. "International competitiveness will be very important. It is important to keep abreast of new developments and good manufacturing practices”, he said. He also noted that the Government has come up with many schemes like the PLI for APIs and for medical devices.
Shri Prasada said, “The three day pharma expo IPHEX will offer the domestic industry majors from India and all across the world a great platform to connect and do business. It will provide you with an opportunity to meet new and existing customers actively looking for new suppliers, or looking to assess the current progress of existing projects.”
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News